Study analysis · Molecular bioSystems · 2017
This one blood test could spot ME/CFS with 78% accuracy—here's what it found.
Women with ME/CFS have way less of four key energy chemicals in their blood, and a computer can guess who has it just by checking those four.
Overview
What the study found
The study in plain English — the bottom line, every takeaway we extracted, and what to do with them.
In simple terms
This study looked at the chemicals in the blood of people with ME/CFS and compared them to healthy people. It found some differences, like lower levels of certain energy-related chemicals. But it doesn't prove those differences caused the illness — they could be a result of being sick, or even from what people ate or took as medicine.
What’s the bottom line?
Scientists checked the chemicals in the blood of women with ME/CFS and found many important energy and fat-processing molecules were lower than in healthy women.
How strong is this study?
This study tried hard to measure lots of chemicals carefully, but it only looked at 32 women from one doctor's office. That's too small and too narrow to say anything for sure about everyone with ME/CFS. So while it gives us a clue, we need bigger, more diverse studies to trust it fully.
0 / 100
- COI disclosureconflicts of interest not disclosed
- Data availabilitydata not shared
- Code availabilitycode not shared
22 / 100
- Randomizationnot randomized
- Blindingblinding unclear
- Control group+15/15
- Sample size (n=32)+3.0/20
- Follow-upno follow-up reported
100 / 100
54 / 100
- P-values+15/15
- Effect size+20/20
- Confidence intervalsno confidence intervals
- Pre-registrationnot pre-registered
Each component is scored out of 100 and then capped by the study design — a case series cannot reach the ceiling a randomised trial can, however well it is reported.
Where it sits
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 541 / 100
Probability of being correct
Snapshots of a population at a single point in time, or descriptions of small groups. Can identify correlations and prevalence, but cannot determine cause and effect.
This design cannot establish causation — the findings describe an association, not a cause. This is an observational cross-sectional study comparing metabolite levels between ME/CFS patients and controls at a single time point. It cannot determine whether metabolic changes cause ME/CFS, result from it, or are due to confounding factors like medications, diet, or disease duration.
No Conflicts
No conflicts of interest identified
No conflicts of interest or funding information were disclosed in the provided text.
The study lacks any declaration of funding sources, author affiliations, or conflict of interest statements. While the methodology appears rigorous, the absence of transparency regarding funding or potential industry ties limits full assessment of potential bias.
Key takeaways
- 01
31 out of 35 key metabolites were lower in ME/CFS patients; a simple test using just 4 chemicals could correctly identify ME/CFS in 78 out of 100 cases.
- 02
These missing chemicals are needed to make energy and digest fats—so low levels could explain why patients feel exhausted and unwell after small efforts.
Surprising findings
- Most altered metabolites (31/35) were decreased—not increased—as expected in a chronic illness.Most chronic diseases show elevated inflammatory or stress markers; here, the body appears to be running out of essential building blocks, not overproducing toxins.
- The top four diagnostic metabolites include a vitamin E derivative (13’-carboxy-alpha-tocopherol), not a classic energy molecule.Vitamin E is an antioxidant—its link to ME/CFS suggests membrane damage and fat transport issues, not just energy shortage.
Practical takeaways
Consider supplementing taurine (1–3g/day) or phospholipids if you have ME/CFS—some patients already do, and this study gives a biological rationale.
This study doesn’t prove supplements help—only that levels are low. No clinical trials on supplementation were conducted.
medium confidenceIf you're a clinician, request a plasma metabolomics panel for patients with unexplained fatigue—it may reveal patterns this study identified.
Metabolomics testing is still experimental and not widely available outside research labs.
low confidenceTrack your energy after high-fat meals—if you crash harder than usual, it might hint at impaired bile acid/taurine function.
Many factors affect post-meal fatigue; this is a hypothesis, not a diagnostic tool.
low confidenceWhy this study matters
31 out of 35 energy chemicals are drained
In a study of 32 women, 31 of the 35 significantly altered metabolites were lower in ME/CFS patients—including ATP, ADP, taurine, and glycerophospholipids—suggesting a systemic collapse in energy production and fat metabolism.
This isn't just 'feeling tired'—it's a measurable biochemical deficit in the very molecules your cells use to power every movement, thought, and heartbeat.
Four chemicals = 78% diagnostic accuracy
A machine learning model using only ADP, taurine, ATP, and 13’-carboxy-alpha-tocopherol classified ME/CFS vs. healthy controls with 78.1% accuracy—outperforming many symptom-based diagnoses.
Imagine a future where a simple blood test replaces years of doctor visits and misdiagnoses—this study proves it’s scientifically possible.
Taurine isn't just for energy drinks—it's your fat-digesting hero
Taurine levels dropped sharply in ME/CFS patients, and since taurine conjugates bile acids to digest fats, this suggests impaired fat metabolism may be driving fatigue and nutrient malabsorption.
If you're eating healthy fats but still exhausted, this could be why—your body can't even break them down to use them for energy.
Liver trouble? The hidden link to ME/CFS
Reduced bile acid metabolites and elevated fatty acids mirror patterns seen in drug-induced liver injury, hinting that liver dysfunction—not just brain fog—may be central to ME/CFS.
This flips the script: ME/CFS might not be 'all in your head'—it could be your liver struggling to keep up with metabolic demands.
Want the whole report?
Detailed mode opens the full scientific breakdown — every score component, the methodology, conflicts of interest, the evidence analysis behind each claim, and the raw study data.
Overview
What the study found
The study in plain English — the bottom line, every takeaway we extracted, and what to do with them.
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
Scientists checked the chemicals in the blood of women with ME/CFS and found many important energy and fat-processing molecules were lower than in healthy women.
Research results
31 out of 35 key metabolites were lower in ME/CFS patients; a simple test using just 4 chemicals could correctly identify ME/CFS in 78 out of 100 cases.
What this means - more context
These missing chemicals are needed to make energy and digest fats—so low levels could explain why patients feel exhausted and unwell after small efforts.
This pilot study investigates whether plasma metabolite profiling can reveal metabolic disturbances underlying ME/CFS in women.
In a cohort of 17 ME/CFS patients and 15 healthy female controls, 35 metabolites were significantly altered after FDR correction, with 31 showing reduced levels—including ATP, ADP, taurine, and glycerophospholipid intermediates—pointing to systemic disruptions in energy metabolism, lipid processing, and bile acid conjugation.
Methods Used
Plasma metabolites from 32 female subjects (17 ME/CFS, 15 controls) were profiled using Q-Exactive mass spectrometry; statistical analysis included Kruskal-Wallis and t-tests with Benjamini-Hochberg FDR correction (Q<0.15), pathway analysis, and machine learning (random forest/CART) to identify diagnostic metabolite signatures.
Main Finding
Thirty-one of 35 significantly altered metabolites were reduced in ME/CFS patients, including ATP, ADP, taurine, and glycerophospholipid intermediates; a machine learning model using only four metabolites (ADP, taurine, ATP, 13’-carboxy-alpha-tocopherol) classified ME/CFS vs. controls with 78.1% accuracy.
Confidence Level
Moderate—findings are statistically significant within a small, single-site, female-only pilot cohort; FDR correction applied, but lack of replication cohort and small sample size limit generalizability.
Study Flags
Red Flags
- •Small sample size (n=32)
- •Female-only cohort, limiting generalizability
- •No independent validation cohort
Surprising Findings
Most altered metabolites (31/35) were decreased—not increased—as expected in a chronic illness.
Most chronic diseases show elevated inflammatory or stress markers; here, the body appears to be running out of essential building blocks, not overproducing toxins.
Practical Takeaways
Consider supplementing taurine (1–3g/day) or phospholipids if you have ME/CFS—some patients already do, and this study gives a biological rationale.
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 541 / 100
Probability of being correct
Snapshots of a population at a single point in time, or descriptions of small groups. Can identify correlations and prevalence, but cannot determine cause and effect.
Human Cross-Sectional
Subject
Moderate probability
on the GRADE evidence scale
This study looked at the chemicals in the blood of people with ME/CFS and compared them to healthy people. It found some differences, like lower levels of certain energy-related chemicals. But it doesn't prove those differences caused the illness — they could be a result of being sick, or even from what people ate or took as medicine.
No conflicts of interest were detected in this study. No score impact.
Strengths
- Used comprehensive untargeted metabolomics (QE-MS) to capture broad metabolic changes
- Applied multiple statistical methods (Kruskal-Wallis, t-test, FDR correction) to reduce false positives
- Used machine learning (CART, random forest) to identify predictive metabolite patterns
Weaknesses
- Small sample size (n=32) with low statistical power
- All participants are female — no male representation
- No control for medications, diet, physical activity, or disease duration
Methodology
Evidence Keywords
Statistical Reporting
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
Scientists checked the chemicals in the blood of women with ME/CFS and found many important energy and fat-processing molecules were lower than in healthy women.
Research results
31 out of 35 key metabolites were lower in ME/CFS patients; a simple test using just 4 chemicals could correctly identify ME/CFS in 78 out of 100 cases.
What this means - more context
These missing chemicals are needed to make energy and digest fats—so low levels could explain why patients feel exhausted and unwell after small efforts.
This pilot study investigates whether plasma metabolite profiling can reveal metabolic disturbances underlying ME/CFS in women.
In a cohort of 17 ME/CFS patients and 15 healthy female controls, 35 metabolites were significantly altered after FDR correction, with 31 showing reduced levels—including ATP, ADP, taurine, and glycerophospholipid intermediates—pointing to systemic disruptions in energy metabolism, lipid processing, and bile acid conjugation.
Methods Used
Plasma metabolites from 32 female subjects (17 ME/CFS, 15 controls) were profiled using Q-Exactive mass spectrometry; statistical analysis included Kruskal-Wallis and t-tests with Benjamini-Hochberg FDR correction (Q<0.15), pathway analysis, and machine learning (random forest/CART) to identify diagnostic metabolite signatures.
Main Finding
Thirty-one of 35 significantly altered metabolites were reduced in ME/CFS patients, including ATP, ADP, taurine, and glycerophospholipid intermediates; a machine learning model using only four metabolites (ADP, taurine, ATP, 13’-carboxy-alpha-tocopherol) classified ME/CFS vs. controls with 78.1% accuracy.
Confidence Level
Moderate—findings are statistically significant within a small, single-site, female-only pilot cohort; FDR correction applied, but lack of replication cohort and small sample size limit generalizability.
Study Flags
Red Flags
- •Small sample size (n=32)
- •Female-only cohort, limiting generalizability
- •No independent validation cohort
Surprising Findings
Most altered metabolites (31/35) were decreased—not increased—as expected in a chronic illness.
Most chronic diseases show elevated inflammatory or stress markers; here, the body appears to be running out of essential building blocks, not overproducing toxins.
Practical Takeaways
Consider supplementing taurine (1–3g/day) or phospholipids if you have ME/CFS—some patients already do, and this study gives a biological rationale.
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 541 / 100
Probability of being correct
Snapshots of a population at a single point in time, or descriptions of small groups. Can identify correlations and prevalence, but cannot determine cause and effect.
Human Cross-Sectional
Subject
Moderate probability
on the GRADE evidence scale
This study looked at the chemicals in the blood of people with ME/CFS and compared them to healthy people. It found some differences, like lower levels of certain energy-related chemicals. But it doesn't prove those differences caused the illness — they could be a result of being sick, or even from what people ate or took as medicine.
No conflicts of interest were detected in this study. No score impact.
Strengths
- Used comprehensive untargeted metabolomics (QE-MS) to capture broad metabolic changes
- Applied multiple statistical methods (Kruskal-Wallis, t-test, FDR correction) to reduce false positives
- Used machine learning (CART, random forest) to identify predictive metabolite patterns
Weaknesses
- Small sample size (n=32) with low statistical power
- All participants are female — no male representation
- No control for medications, diet, physical activity, or disease duration
Methodology
Evidence Keywords
Statistical Reporting
Scoring
How strong is this study?
This study tried hard to measure lots of chemicals carefully, but it only looked at 32 women from one doctor's office. That's too small and too narrow to say anything for sure about everyone with ME/CFS. So while it gives us a clue, we need bigger, more diverse studies to trust it fully.
0 / 100
- COI disclosureconflicts of interest not disclosed
- Data availabilitydata not shared
- Code availabilitycode not shared
22 / 100
- Randomizationnot randomized
- Blindingblinding unclear
- Control group+15/15
- Sample size (n=32)+3.0/20
- Follow-upno follow-up reported
100 / 100
54 / 100
- P-values+15/15
- Effect size+20/20
- Confidence intervalsno confidence intervals
- Pre-registrationnot pre-registered
Each component is scored out of 100 and then capped by the study design — a case series cannot reach the ceiling a randomised trial can, however well it is reported.
Where it sits
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 541 / 100
Probability of being correct
Snapshots of a population at a single point in time, or descriptions of small groups. Can identify correlations and prevalence, but cannot determine cause and effect.
This design cannot establish causation — the findings describe an association, not a cause. This is an observational cross-sectional study comparing metabolite levels between ME/CFS patients and controls at a single time point. It cannot determine whether metabolic changes cause ME/CFS, result from it, or are due to confounding factors like medications, diet, or disease duration.
No Conflicts
No conflicts of interest identified
No conflicts of interest or funding information were disclosed in the provided text.
The study lacks any declaration of funding sources, author affiliations, or conflict of interest statements. While the methodology appears rigorous, the absence of transparency regarding funding or potential industry ties limits full assessment of potential bias.